Finance

Lists
HROW:NASDAQ
Harrow Inc
$30.80
-1.91%
(-0.60) 1D
$30.93
+0.42% (+0.13)
After hours
Closed: Sep 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HROW...
Open
$31.62
High
$31.86
Low
$30.76
Mkt. cap
1.15B
Avg. vol.
549.66K
Volume
514.37K
52-wk high
$54.85
52-wk low
$28.54
EPS
-$1.00
Beta
0.24
Shares outstanding
37.49M
No. of employees
373
Open
$31.62
High
$31.86
Low
$30.76
Mkt. cap
1.15B
Avg. vol.
549.66K
Volume
514.37K
52-wk high
$54.85
52-wk low
$28.54
EPS
-$1.00
Beta
0.24
Shares outstanding
37.49M
No. of employees
373
News stories
From web sources and news partners
About Harrow Inc
CEO-
Employees373
Founded1998
HeadquartersNashville, Tennessee, United States
SectorPharmaceutical industry
Websiteharrow.com
Analyst ratings
Based on 8 analysts giving stock ratings to HROW in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for HROW in the last 3 months.
Highest
Current $30.80
$88.00 (+185.71%)
Average
$63.57 (+106.40%)
Lowest
$45.00 (+46.10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Clark
Leerink Partners
Buy
Initiated
$45.00
+46.1%
09/09/2026
Thomas Shrader
BTIG
Buy
Maintained
$63.00
+104.5%
08/25/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
08/20/2026
Thomas Flaten
Lake Street
Buy
Maintained
$60.00
+94.8%
08/20/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$70.00
+127.3%
08/12/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$88.00
+185.7%
08/10/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$60.00
+94.8%
08/10/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
$59.00
+91.6%
07/13/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
$62.00
+101.3%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
71.64M
89.09M
44.20M
70.66M
Cost of goods sold
17.71M
18.47M
17.16M
20.30M
Cost of revenue
17.71M
18.47M
17.16M
20.30M
Research and development expenses
3.32M
11.72M
5.90M
8.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.86M
43.31M
43.23M
53.30M
Operating expense
39.18M
55.03M
49.12M
61.37M
Total operating expenses
56.89M
73.50M
66.28M
81.67M
Operating income
14.75M
15.59M
-22.08M
-11.01M
Other non operating income
61.00K
-8.00K
-
-
EBT including unusual items
1.02M
10.40M
-27.58M
-17.27M
EBT excluding unusual items
8.77M
10.40M
-27.58M
-17.27M
Income tax expense
-
3.77M
25.00K
-
Effective tax rate
-
36.27%
-0.09%
-
Other operating expenses
-
-
-
-
Net income
1.02M
6.63M
-27.60M
-17.27M
Net profit margin
1.42%
7.44%
-62.44%
-24.44%
Earnings per share
0.33
-
-0.74
-0.46
Interest and investment income
-
-
-
-
Interest expense
-6.04M
-5.19M
-5.50M
-6.26M
Net interest expenses
-6.04M
-5.19M
-5.50M
-6.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
19.31M
20.22M
-16.50M
-5.02M
Gain or loss from assets sale
-
13.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps